|Bid||12.74 x 800|
|Ask||12.76 x 800|
|Day's range||11.63 - 12.81|
|52-week range||7.40 - 13.97|
|Beta (5Y monthly)||0.95|
|PE ratio (TTM)||72.15|
|Earnings date||27 Feb 2023 - 03 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||25.00|
Cara Therapeutics ( NASDAQ:CARA ) Third Quarter 2022 Results Key Financial Results Revenue: US$10.8m (down 47% from 3Q...
Cara (CARA) delivered earnings and revenue surprises of -2.38% and 28.91%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cara Therapeutics (CARA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.